| Fi
gures/TablesFi
gures/Tables | ReferencesReferencesml version="1.0" encodin
g="UTF-8"?>
Background & Aims
Perforin plays a central role in the i
mmunopatho
genesis of different viral infections. However, its role in hepatitis C virus (HCV) infection has not been fully understood. Here, we analyzed two closely related questions: first, is CD8+ T cell-
mediated killin
g of HCV-replicatin
g hu
man hepato
ma cells
mediated by perforin? Second, if so, do HCV-specific CD8+ T cells obtained fro
m chronically HCV infected patients express and upre
gulate perforin?
Methods
Susceptibility of HCV-replicating human hepatoma cells to the cytotoxic pathway was tested m>in vitrom> by addition of perforin substitute streptolysin O and granzyme B and by co-culture experiments with a perforin-expressing HCV-specific CD8+ T cell clone in the presence of perforin or caspase inhibitors. HCV-specific CD8+ T cells were obtained and analyzed for perforin expression and differentiation markers m>ex vivom> from 12 chronically infected patients and 12 patients with resolved HCV infection.
Results
HCV-replicating human hepatoma cells were susceptible to cytotoxic killing m>in vitrom> and a dominant role of perforin in HCV-specific CD8+ T cell-mediated cytolysis was observed. However, HCV-specific CD8+ T cells obtained m>ex vivom> from chronically HCV infected patients expressed only low levels of perforin and showed an impaired ability to upregulate perforin. This was tightly linked to the distinct differentiation stage of HCV-specific CD8+ T cell differentiation m>ex vivom> since early and intermediate differentiated HCV-specific CD8+ T cells only showed weak perforin expression in contrast to late differentiated CD8+ T cells that displayed strong perforin expression.
Conclusions
Our results suggest that perforin plays a dominant role in CD8+ T cell-mediated lysis of HCV-replicating human hepatoma cells but that lysis may be limited in human chronic viral infection by the low perforin expression of early/intermediate differentiated HCV-specific CD8+ T cells.